Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call Transcript
2025-08-05 11:23:10 ET
Fresenius Medical Care AG (FMS)
Q2 2025 Earnings Call
August 5, 2025 08:00 A.M. ET
Company Participants
s - Corporate Participant
o - Corporate Participant
P - Corporate Participant
Dominik Heger - Executive VP and Head of Investor Relations, Strategic Development & Communications
Helen Giza - Chair of Management Board & CEO
Martin Fischer - CFO & Member of the Management Board
Conference Call Participants
David James Adlington - JPMorgan Chase & Co, Research Division
Falko Friedrichs - Deutsche Bank AG, Research Division
Graham Doyle - UBS Investment Bank, Research Division
Hassan Al-Wakeel - Barclays Bank PLC, Research Division
Hugo Solvet - BNP Paribas Exane, Research Division
James Alexander Stewart Vane- Tempest - Jefferies LLC, Research Division
Oliver Metzger - ODDO BHF Corporate & Markets, Research Division
Richard Felton - Goldman Sachs Group, Inc., Research Division
Veronika Dubajova - Citigroup Inc., Research Division
a divi - Unidentified Company
ion - Unidentified Company
f S& - Global Inc. All Rights reserved.
Presentation
Operator
Ladies and gentlemen, welcome to the Report on Second Quarter 2025 Conference Call. I am Sandra, the Chorus Call operator. [Operator Instructions] and the conference is being recorded. [Operator Instructions]...
Read the full article on Seeking Alpha
For further details see:
Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call TranscriptNASDAQ: FMCQF
FMCQF Trading
0.0% G/L:
$49.2095 Last:
160 Volume:
$49.2095 Open:



